Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPAVNT · Entity 4061 | Director | September 30, 2026 | October 02, 2026 |
| Anika Therapeutics, Inc.ANIK · Entity 6005 | Director | June 20, 2025 | June 24, 2025 |
| MASIMO CORPMASI · Entity 39014 | Director | August 11, 2025 | August 12, 2025 |
| Medtronic plcMDT · Entity 2888 | Director | April 27, 2026 | April 29, 2026 |
| STRYKER CORPSYK · Entity 369 | VP and CFO | February 11, 2015 | February 12, 2015 |
| Telix Pharmaceuticals LtdTLX · Entity 4101 | Director | May 11, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,132 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 958 · Balance 28,132 |
| Common StockSEC Table I · non-derivative | IndirectDeferred Comp Plan | 44,462.326 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 44,462.326 F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
Anika Therapeutics, Inc.
Report date June 20, 2025 · Filed June 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,403 |
Reported balance
After 2025-06-20 transaction · row 1
1 source rowRow 1 · 2025-06-20 · Grant · Acquired 14,164 · Balance 20,403 F1: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 2,700 |
Reported balance
Holding disclosure · report date 2025-06-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,700 F2: Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.
F2: Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee.
MASIMO CORP
Report date August 11, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,790 |
Reported balance
After 2025-08-11 transaction · row 1
1 source rowRow 1 · 2025-08-11 · Purchase · Acquired 3,000 · Balance 4,790 F1: The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Medtronic plc
Report date April 27, 2026 · Filed April 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 6,444 |
Reported balance
After 2026-04-27 transaction · row 1
1 source rowRow 1 · 2026-04-27 · Grant · Acquired 1,444 · Balance 6,444 F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
STRYKER CORP
Report date February 11, 2015 · Filed February 12, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option granted 02/11/2015 (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.06 · Expires 2025-02-10 | Direct | 26,865 |
Reported balance
After 2015-02-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2015-02-11 · Grant · Acquired 26,865 · Balance 26,865 F1: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.
Telix Pharmaceuticals Ltd
Report date May 11, 2026 · Filed May 18, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 17:25 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000136 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,132 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 15:42 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000112 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,174 Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001189883-26-000002 · wk-form4_1777493719.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,444 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:20 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000080 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,125 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:38 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000013 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,053 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 15:57 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-25-000076 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,814 Read SEC document |
| August 25, 2025 Filed Aug 25, 2025 21:18 UTC | Medtronic plc MDT · Entity 2888 | PurchaseOrdinary Shares | 2,500 | $92.37 | $230,925.00 |
DisclosureSEC source: 0001613103-25-000157 · wk-form4_1756156682.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 F1 · balance_after: Shares are held in joint account with spouse. Read SEC document |
| August 22, 2025 Filed Aug 25, 2025 21:18 UTC | Medtronic plc MDT · Entity 2888 | PurchaseOrdinary Shares | 2,500 | $92.73 | $231,825.00 |
DisclosureSEC source: 0001613103-25-000157 · wk-form4_1756156682.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:20 UTC | MASIMO CORP MASI · Entity 39014 | PurchaseCommon Stock | 3,000 | $145.98 | $437,940.00 |
DisclosureSEC source: 0000937556-25-000123 · wk-form4_1755030008.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,790 F1 · price: The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 18:12 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018578 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,622 Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:12 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 14,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-25-004069 · ownership.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,403 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026. Read SEC document |
| April 29, 2025 Filed May 2, 2025 12:51 UTC | MASIMO CORP MASI · Entity 39014 | GrantRestricted Stock Units · Derivative | 1,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-25-000069 · wk-form4_1746190269.xml · derivative · entry 3 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,225 Underlying: Common Stock · 1,225 shares Expires 2035-04-29 F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F3 · derivative.exercise_date: These RSUs were granted on April 29, 2025 and will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| April 29, 2025 Filed May 2, 2025 12:51 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionRestricted Stock Units · Derivative | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-25-000069 · wk-form4_1746190269.xml · derivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,790 shares Expires 2034-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F2 · derivative.exercise_date: These RSUs were granted on September 19, 2024 and vested in full on the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| April 29, 2025 Filed May 2, 2025 12:51 UTC | MASIMO CORP MASI · Entity 39014 | GrantCommon Stock | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-25-000069 · wk-form4_1746190269.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,790 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 19:35 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011101 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,435 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:03 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000369 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,380 Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:20 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024897 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,425 Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 22:27 UTC | MASIMO CORP MASI · Entity 39014 | GrantRestricted Stock Units · Derivative | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-24-000080 · wk-form4_1727130458.xml · derivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2034-09-19 F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F2 · derivative.exercise_date: These RSUs were granted on September 19, 2024 and will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant. Read SEC document |
| July 09, 2024 Filed Jul 11, 2024 20:33 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 5,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-24-003907 · ownership.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,239 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:11 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019542 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,650 Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:11 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-24-003315 · ownership.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,168 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the next annual meeting of the Company's stockholders or June 3, 2025. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:34 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011600 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,844 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:43 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000247 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,036 Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:21 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 984 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025193 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,202 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:20 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019849 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,218 Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 19:58 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-011896 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,355 Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 19:19 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-000083 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,498 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 17:58 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023173 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,458 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 17:49 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023164 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,458 Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 18:07 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018393 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,319 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:15 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 717 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011136 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,439 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 18:10 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000035 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,722 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026274 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,095 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 12:26 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020884 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,351 Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:38 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012615 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,682 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 17:09 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 742 | $40.44 | $30,006.48 |
DisclosureSEC source: 0001127602-21-000063 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 38,395 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 17:09 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000063 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 37,653 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 18:02 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,109 | $27.04 | $29,987.36 |
DisclosureSEC source: 0001127602-20-025977 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 36,635 Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 18:02 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025977 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 35,526 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 16:03 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020543 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 34,072 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 16:03 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,193 | $26.00 | $31,012.04 |
DisclosureSEC source: 0001127602-20-020543 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 32,822 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 23:12 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,574 | $19.07 | $30,008.31 |
DisclosureSEC source: 0001127602-20-012477 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 31,346 Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 23:12 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012477 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 29,772 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 14:33 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 812 | $37.01 | $30,048.06 |
DisclosureSEC source: 0001127602-20-000318 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 27,917 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 14:33 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000318 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 27,105 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 19:34 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 985 | $32.48 | $31,992.80 |
DisclosureSEC source: 0001127602-19-029361 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 26,078 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 19:34 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029361 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 25,093 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 13:26 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023319 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 23,964 Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 13:26 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 974 | $30.80 | $29,994.33 |
DisclosureSEC source: 0001127602-19-023319 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 22,909 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 19:59 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014091 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 21,810 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.